Ropes & Gray: In BioCentury, David McIntosh Discusses Implications of Biosecure Act on Biopharmaceutical Companies
March 28, 2024
March 28, 2024
BOSTON, Massachusetts, March 28 -- Ropes and Gray, a law firm, issued the following news:
In a BioCentury article, life sciences licensing partner David McIntosh discussed potential implications of the Biosecure Act to address concerns that Chinese biotechnology companies pose national security threats.
David notes the U.S. Senate bill was amended to grandfather existing contracts, but it is not yet clear how the grandfathering process will apply.
"Gra . . .
In a BioCentury article, life sciences licensing partner David McIntosh discussed potential implications of the Biosecure Act to address concerns that Chinese biotechnology companies pose national security threats.
David notes the U.S. Senate bill was amended to grandfather existing contracts, but it is not yet clear how the grandfathering process will apply.
"Gra . . .